Skip to main content
. 2012 Dec 11;4:163–172. doi: 10.2147/JEP.S35326

Table 7.

Nootropics and vascular dementia

Reference Title Main results Study type Patients randomized
Alvarez-Sabín and Román50 Citicoline in vascular cognitive impairment and vascular dementia after stroke Citicoline prevents cognitive decline after stroke and improves time orientation, attention and executive functions Review NA
García-Cobos et al51 Citicoline, use in cognitive decline: vascular and degenerative Citicoline improves recovery and cognitive improvement after stroke Review NA
Muresanu et al52 Persistence of the effects of cerebrolysin on cognition and qEEG slowing in vascular dementia patients: results of a 3-month extension study Cerebrolysin produces significant improvements in cognitive function Clinical trial, randomized, double-blind 33 patients
Guekht et al53 Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial Cerebrolysin produces significant improvements in cognitive function Clinical trial, randomized, double-blind 242 patients